Multidrug resistance (MDR) among uropathogens is a global public health problem (Mathai et al., 2001). In UTI cases there is a need to start treatment before the final microbiological results are available. Area-specific monitoring studies aimed to gain knowledge about the type of pathogens responsible for UTIs and their resistance patterns may help the clinician to choose the right empirical treatment (Stamm et al., 2001). |